BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12635015)

  • 21. Can Endorectal Ultrasound, MRI, and Mucosa Integrity Accurately Predict the Complete Response for Mid-Low Rectal Cancer After Preoperative Chemoradiation? A Prospective Observational Study from a Single Medical Center.
    Liu S; Zhong GX; Zhou WX; Xue HD; Pan WD; Xu L; Lu JY; Wu B; Lin GL; Qiu HZ; Xiao Y
    Dis Colon Rectum; 2018 Aug; 61(8):903-910. PubMed ID: 29944579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors.
    Akashi M; Nakahusa Y; Yakabe T; Egashira Y; Koga Y; Sumi K; Noshiro H; Irie H; Tokunaga O; Miyazaki K
    Acta Radiol; 2014 Jun; 55(5):524-31. PubMed ID: 24005562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?
    Chen CC; Lee RC; Lin JK; Wang LW; Yang SH
    Dis Colon Rectum; 2005 Apr; 48(4):722-8. PubMed ID: 15747073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma.
    DeVries AF; Kremser C; Hein PA; Griebel J; Krezcy A; Ofner D; Pfeiffer KP; Lukas P; Judmaier W
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):958-65. PubMed ID: 12829130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can diffusion-weighted MRI determine complete responders after neoadjuvant chemoradiation for locally advanced rectal cancer?
    Engin G; Sharifov R; Güral Z; Sağam EK; Sağlam S; Balik E; Asoğu O; Yamaner S; Güllüoğu M; Kapran Y; Özel S
    Diagn Interv Radiol; 2012; 18(6):574-81. PubMed ID: 22798154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized magnetic resonance imaging-based neoadjuvant chemoradiation for middle and lower rectal carcinoma.
    Hermanek P; Hohenberger W; Fietkau R; Rödel C
    Colorectal Dis; 2011 Jan; 13(1):39-47. PubMed ID: 19863611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility evaluation of diffusion-weighted imaging using an integrated MRI-radiotherapy system for response assessment to neoadjuvant therapy in rectal cancer.
    Shaverdian N; Yang Y; Hu P; Hart S; Sheng K; Lamb J; Cao M; Agazaryan N; Thomas D; Steinberg M; Low DA; Lee P
    Br J Radiol; 2017 Mar; 90(1071):20160739. PubMed ID: 28079398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study.
    Caravatta L; Padula GD; Picardi V; Macchia G; Deodato F; Massaccesi M; Sofo L; Pacelli F; Rotondi F; Cecere G; Sallustio G; Di Lullo L; Piscopo A; Mignogna S; Bonomo P; Cellini N; Valentini V; Morganti AG
    Acta Oncol; 2011 Nov; 50(8):1151-7. PubMed ID: 21851185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion MRI for rectal cancer staging: ADC measurements before and after ultrasonographic gel lumen distension.
    Palmucci S; Piccoli M; Piana S; Foti PV; Siverino ROA; Mauro LA; Milone P; Ettorre GC
    Eur J Radiol; 2017 Jan; 86():119-126. PubMed ID: 28027737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
    Weber MA; Bender K; von Gall CC; Stange A; Grünberg K; Ott K; Haberkorn U; Kauczor HU; Zechmann C
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):45-52. PubMed ID: 23539390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    De Felice F; Magnante AL; Musio D; Ciolina M; De Cecco CN; Rengo M; Laghi A; Tombolini V
    Eur J Surg Oncol; 2017 Jul; 43(7):1324-1329. PubMed ID: 28363512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT.
    Ippolito D; Monguzzi L; Guerra L; Deponti E; Gardani G; Messa C; Sironi S
    Abdom Imaging; 2012 Dec; 37(6):1032-40. PubMed ID: 22270580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cyto-reduction of rectal cancer after preoperative chemoradiotherapy].
    Sánchez Maldonado W; Rodríguez Coria D; Luna Pérez P
    Rev Gastroenterol Mex; 1995; 60(3):158. PubMed ID: 7481450
    [No Abstract]   [Full Text] [Related]  

  • 37. Adjuvant radiation therapy for rectal carcinoma: predictors of outcome.
    Myerson RJ; Michalski JM; King ML; Birnbaum E; Fleshman J; Fry R; Kodner I; Lacey D; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):41-50. PubMed ID: 7721638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
    Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
    Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy.
    Allen SD; Padhani AR; Dzik-Jurasz AS; Glynne-Jones R
    AJR Am J Roentgenol; 2007 Feb; 188(2):442-51. PubMed ID: 17242254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative staging of rectal cancer using magnetic resonance imaging: comparison with pathological staging.
    Faletti R; Gatti M; Arezzo A; Stola S; Benedini MC; Bergamasco L; Morino M; Fonio P
    Minerva Chir; 2018 Feb; 73(1):13-19. PubMed ID: 28497665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.